
Why pay $50 billion for the headache known as Tylenol?
Marketplace All-in-One
00:00
Kimberly‑Clark’s Big Bet on Kenvue and Tylenol Liability
Carla Javier examines Kimberly‑Clark's proposed acquisition of Kenvue, the litigation over Tylenol, and potential risks and savings.
Play episode from 03:01
Transcript


